Journal
BENEFICIAL MICROBES
Volume 6, Issue 6, Pages 799-806Publisher
WAGENINGEN ACADEMIC PUBLISHERS
DOI: 10.3920/BM2015.0015
Keywords
probiotics; Bifidobacterium; inflammation; gout
Categories
Funding
- Conselho Nacional de Pesquisa (CNPq)
- Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)
Ask authors/readers for more resources
Gout is an acute inflammatory disease characterised by the presence of uric acid crystals in the joint. This event promotes neutrophil infiltration and activation that leads to tissue damage. We investigated here whether the oral administration of the probiotic strain Bifidobacterium longum 5(1A) (BL) could ameliorate monosodium urate crystal (MSU)-induced inflammation in a murine model of gout. Mice received oral administration of BL or saline daily for 7 days and then were injected with MSU in the knee cavity. Treatment with BL significantly alleviated the inflammatory parameters, as seen by reduced hypernociception, reduced neutrophil accumulation in the joint and myeloperoxidase activity in periarticular tissue. There was inhibition of the production of CXCL1 and interleukin(IL)-1 beta in joints. Levels of the anti-inflammatory cytokine IL-10 were significantly higher in the knee tissue of mice treated with than control mice injected with MSU. In conclusion, oral BL treatment reduced the inflammatory response in an experimental murine model of gout, suggesting it may be useful as an adjuvant treatment in patients with gout.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available